Vous avez sélectionné la vue dans Anglais
Descripteur en français: | Naltrexone | ||||||
Descripteur en anglais: | Naltrexone | ||||||
Descripteur en espagnol: |
Naltrexona
| ||||||
Descripteur en portugais: | Naltrexona | ||||||
Synonymes: |
Antaxone Celupan EN 1639A EN-1639A EN1639A Nalorex Naltrexone Hydrochloride Nemexin ReVia Trexan |
||||||
Code(s) d'arborescence: |
D03.132.577.249.706.550 D03.605.497.750.550 D03.633.400.686.750.550 D04.615.723.795.706.550 |
||||||
Identificateur unique RDF: | https://id.nlm.nih.gov/mesh/D009271 | ||||||
Note d'application: | Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. |
||||||
Qualificatifs autorisés: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Action Pharmacologique: |
Substances à effet antabuse Antagonistes narcotiques |
||||||
Numéro de registre: | 5S6W795CQM | ||||||
Nom CAS Type 1: | Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)- | ||||||
Indexation précédente: |
Cyclopropanes (1973-1975) Morphinans (1973-1974) Naloxone/analogs & derivatives (1975) |
||||||
Note publique MeSH: | 1986; NALTREXONE was indexed under NALOXONE 1976-1985 |
||||||
Note historique: | 1986 (1976) |
||||||
Identifiant DeCS: | 9463 | ||||||
ID du Descripteur: | D009271 | ||||||
Classification de la NLM: | QV 89 | ||||||
Documents indexés dans la Biblioteque Virtuelle de Santé (BVS): | Cliquez ici pour accéder aux documents VHL | ||||||
Date d'établissement: | 01/01/1986 | ||||||
Date d'entrée: | 23/07/1975 | ||||||
Date de révision: | 10/04/2018 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Naltrexone
- Concept préféré
Antaxone
- Plus spécifique
Trexan
- Plus spécifique
EN-1639A
- Plus spécifique
ReVia
- Plus spécifique
Naltrexone Hydrochloride
- Plus spécifique
Celupan
- Plus spécifique
Concept UI |
M0014445 |
Note d'application | Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. |
Terme préféré | Naltrexone |
Concept UI |
M0462923 |
Terme préféré | Antaxone |
Concept UI |
M0352956 |
Terme préféré | Trexan |
Concept UI |
M0014444 |
Terme préféré | EN-1639A |
Synonymes |
EN 1639A EN1639A |
Concept UI |
M0462925 |
Terme préféré | ReVia |
Synonymes |
Nalorex Nemexin |
Concept UI |
M0462922 |
Terme préféré | Naltrexone Hydrochloride |
Concept UI |
M0462924 |
Terme préféré | Celupan |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey